These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 11499150

  • 1. [Modern osteoporosis therapy. Only once weekly against osteoporosis].
    MMW Fortschr Med; 2001 Jul 19; 143(28-29):52-3. PubMed ID: 11499150
    [No Abstract] [Full Text] [Related]

  • 2. [Bisphosphonates once weekly. Osteoporosis therapy becomes more effective].
    MMW Fortschr Med; 2001 Jul 26; 143(30):44-5. PubMed ID: 11524987
    [No Abstract] [Full Text] [Related]

  • 3. [An advantage for compliance: alendronate once weekly].
    MMW Fortschr Med; 2005 Dec 08; 147(49-50):75. PubMed ID: 16401017
    [No Abstract] [Full Text] [Related]

  • 4. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss.
    Choi HJ, Im JA, Kim SH.
    Maturitas; 2008 Jun 20; 60(2):170-6. PubMed ID: 18572334
    [Abstract] [Full Text] [Related]

  • 5. Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy.
    Palomba S, Orio F, Russo T, Colao A, Lombardi G, Zullo F.
    Fertil Steril; 2004 Feb 20; 81(2):476-8. PubMed ID: 14967398
    [Abstract] [Full Text] [Related]

  • 6. Acute polyarthritis related to once-weekly alendronate in a woman with osteoporosis.
    Gerster JH.
    J Rheumatol; 2004 Apr 20; 31(4):829-30. PubMed ID: 15095748
    [No Abstract] [Full Text] [Related]

  • 7. Patients with osteoporosis prefer once weekly to once daily dosing with alendronate.
    Kendler D, Kung AW, Fuleihan Gel-H, González González JG, Gaines KA, Verbruggen N, Melton ME.
    Maturitas; 2004 Jul 15; 48(3):243-51. PubMed ID: 15207890
    [Abstract] [Full Text] [Related]

  • 8. [Osteoporosis and bisphosphonates].
    Zuber MA.
    Z Rheumatol; 2007 Dec 15; 66(8):713-5. PubMed ID: 17955251
    [No Abstract] [Full Text] [Related]

  • 9. By the way, doctor. I recently heard that I can take Fosamax once a week for osteoporosis, rather than every day. Is it really effective when taken this way? Is there a downside?
    Robb-Nicholson C.
    Harv Womens Health Watch; 2001 May 15; 8(9):8. PubMed ID: 11410457
    [No Abstract] [Full Text] [Related]

  • 10. Spine studies to remain part of bone analysis.
    Diagn Imaging (San Franc); 1998 Nov 15; Suppl Bone Mass():6. PubMed ID: 10345144
    [No Abstract] [Full Text] [Related]

  • 11. [Alendronate once a week].
    Brixen KT, Mosekilde L.
    Ugeskr Laeger; 2003 Jun 30; 165(27):2734-9. PubMed ID: 12886563
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M, Recker R, Miller P, Fiske D, Minkoff J, Kriegman A, Zhou W, Adera M, Davis J.
    Bone; 2007 Jul 30; 41(1):122-8. PubMed ID: 17468062
    [Abstract] [Full Text] [Related]

  • 13. [Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show].
    Praxis (Bern 1994); 2004 Sep 01; 93(36):1454. PubMed ID: 15487859
    [No Abstract] [Full Text] [Related]

  • 14. [Patients evaluate osteoporosis therapy. Once a week is preferred].
    MMW Fortschr Med; 2002 Oct 03; 144(40):50. PubMed ID: 12440301
    [No Abstract] [Full Text] [Related]

  • 15. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB.
    Ann Pharmacother; 2008 Jul 03; 42(7):1085-9. PubMed ID: 18505912
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Parathyroid and bone. Role of parathyroid hormone in the treatment of osteoporosis].
    Nakamura T.
    Clin Calcium; 2007 Dec 03; 17(12):1823-9. PubMed ID: 18057656
    [Abstract] [Full Text] [Related]

  • 18. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
    Gold DT, Martin BC, Frytak JR, Amonkar MM, Cosman F.
    Curr Med Res Opin; 2007 Mar 03; 23(3):585-94. PubMed ID: 17355739
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Alendronate in the treatment of postmenopausal osteoporosis.
    Hosking DJ, Favus M, Yates AJ.
    Int J Clin Pract Suppl; 1999 Apr 03; 101():27-35. PubMed ID: 12669738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.